Advertisement

Topics

Vasomotor Symptoms of Menopause Pipeline Insight, 2017 [Report Updated: 10072017] Prices from USD $1500

02:02 EDT 30 Jul 2017 | BioPortfolio Reports

DelveInsight's, Vasomotor Symptoms of Menopause Pipeline Insights, 2017, report provides comprehensive insights about pipeline drugs across this Vasomotor Symptoms of Menopause. The key objective of the report is to establish the understanding for all the pipeline drugs that are undergoing research across Vasomotor Symptoms of Menopause. This report provides information on the therapeutic development for Vasomotor Symptoms of Menopause, dealing with all the pipeline drugs and comparative analysis at various stages covering all clinical, preclinical as well as discovery products. The report further contains details on dormant products and discontinued products. Therapeutic assessment of all the active products by route of administration and molecule type is also covered in this report.
The report is built using data and information sourced from proprietary databases, primary and secondary research and inhouse analysis by DelveInsight team of industry experts.
Secondary sources information and data has been collected from various printable and nonprintable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.
Endoceutics
Therapeutics MD
Nerre Therapeutics Ltd.
Radius Health Inc.
Pherin Pharmaceuticals Inc.
Mithra Pharmaceuticals.
Euroscreen S.A
Yung Shin Pharmaceutical
Ausio Pharmaceuticals
Millendo Therapeutics Inc.
MenoGeniX Inc
Mitsubishi Tanabe Pharma Corporation
Fervent Pharmaceuticals
QUE Oncology
Hibernaid Inc.
Eaton Scientific Systems
Merck
Solvay pharmaceutical
Arbor Pharmaceuticals
Bionovo
Pfizer
Depomed
NovaDel
Shionogi Pharma
Bayer
Janssen Pharmaceuticals Inc.
GlaxoSmithKline
Concert Pharmaceuticals
Edgemont Pharmaceuticals
Karo Bio and Merck Co.'
Barr Laboratories
Eli Lilly
Amgen/ Novartis
ANI Pharmaceuticals/Endo
Pivot Pharmaceuticals

Vasomotor Symptoms of Menopause Pipeline Drugs
Vasomotor Symptoms of Menopause Pipeline Assessment
Vasomotor Symptoms of Menopause Pipeline Analysis
Vasomotor Symptoms of Menopause Drugs under Development
Vasomotor Symptoms of Menopause Discovery drugs
Vasomotor Symptoms of Menopause Preclinical drugs
Vasomotor Symptoms of Menopause Phase I drugs
Vasomotor Symptoms of Menopause Phase II drugs
Vasomotor Symptoms of Menopause Phase III Pipeline Drugs Assessment
Vasomotor Symptoms of Menopause Preregistration drugs
Vasomotor Symptoms of Menopause Molecules in pipeline

Original Article: Vasomotor Symptoms of Menopause Pipeline Insight, 2017 [Report Updated: 10072017] Prices from USD $1500

NEXT ARTICLE

More From BioPortfolio on "Vasomotor Symptoms of Menopause Pipeline Insight, 2017 [Report Updated: 10072017] Prices from USD $1500"

Quick Search
Advertisement
 

Relevant Topics

Menopause
The menopause is a natural event for all women; the ovaries no longer produce estrogen and progesterone. This can be due to natural aging (usual age of onset is 51 years), or through chemotherapy and surgery on the ovaries. The changing balance of the ho...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...